Peters XQ - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Zoning in on Tankyrases: A Brief Review on the Past, Present and Prospective Studies.

Peters XQ, Malinga TH, Agoni C, Olotu FA, Soliman MES. Peters XQ, et al. Anticancer Agents Med Chem. 2019;19(16):1920-1934. doi: 10.2174/1871520619666191019114321. Anticancer Agents Med Chem. 2019. PMID: 31648650 Review.

Unravelling the Structural Mechanism of Action of 5-methyl-5-[4-(4-oxo-3H-quinazolin-2-yl)phenyl]imidazolidine-2,4-dione in Dual-Targeting Tankyrase 1 and 2: A Novel Avenue in Cancer Therapy.

Peters XQ, Agoni C, Soliman MES. Peters XQ, et al. Cell Biochem Biophys. 2022 Sep;80(3):505-518. doi: 10.1007/s12013-022-01076-2. Epub 2022 May 30. Cell Biochem Biophys. 2022. PMID: 35637423

Pharmacophore-based Identification of Potential Mutant Isocitrate Dehydrogenases I/2 Inhibitors: An Explorative Avenue in Cancer Drug Design.

Poonan P, Peters XQ, Soliman MES, Alahmdi MI, Abo-Dya NE. Poonan P, et al. Among authors: peters xq. Anticancer Agents Med Chem. 2023;23(8):953-966. doi: 10.2174/1871520623666221129163001. Anticancer Agents Med Chem. 2023. PMID: 36453510

Therapeutic Path to Triple Knockout: Investigating the Pan-inhibitory Mechanisms of AKT, CDK9, and TNKS2 by a novel 2-Phenylquinazolinone derivative in Cancer Therapy- An In-Silico Investigation.

Peters XQ, Elamin G, Aljoundi A, Alahmdi MI, Abo-Dya NE, Sidhom PA, Tawfeek AM, Ibrahim MAA, Soremekun O, Soliman MES. Peters XQ, et al. Curr Pharm Biotechnol. 2023 Aug 15. doi: 10.2174/1389201024666230815145001. Online ahead of print. Curr Pharm Biotechnol. 2023. PMID: 37581526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4 results

Search Page